Task: Answer the multiple choice question.
Query: Which drug exhibits a 0.901\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. COCCNC(=O)c1cccc(OC2CCN(Cc3ccccc3OC(F)F)CC2)c1
b. C(=N/c1nccs1)\c1cccnc1
c. COc1cc(C2=NOC(C(=O)NCc3ccco3)C2)cc(OC)c1OC
d. COc1ccc2nc(C)[nH]c(=O)c2c1
e. COc1ccc(OC)c(NC(=S)NCCCN2CCOCC2)c1
Answer: b. C(=N/c1nccs1)\c1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C(=N/c1nccs1)\c1cccnc1
C(=N/c1nccs1)\c1cccnc1
(E)-1-pyridin-3-yl-N-(1,3-thiazol-2-yl)methanimine